Bison Wealth LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 68.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,317 shares of the healthcare conglomerate's stock after selling 7,130 shares during the quarter. Bison Wealth LLC's holdings in UnitedHealth Group were worth $1,678,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the fourth quarter worth $30,000. Institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on UNH. Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Finally, Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Three equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $596.86.
View Our Latest Research Report on UNH
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded down $11.37 during midday trading on Thursday, hitting $400.07. 9,289,533 shares of the company's stock traded hands, compared to its average volume of 4,571,255. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $364.15 billion, a price-to-earnings ratio of 25.81, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The firm has a fifty day moving average of $497.29 and a 200 day moving average of $529.82. UnitedHealth Group Incorporated has a 1 year low of $399.53 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 35.18%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.